-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
-
Summary
-
China SXT Pharmaceuticals, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and change rate from Q1 2022 to Q1 2025.
- China SXT Pharmaceuticals, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Mar 2025 was $1,441,907, a 15% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)